SEC 13F Intelligence

Managers / Q3 2024 · view latest →

Privium Fund Management B.V.

CIK 0001795097 · GUSTAV MAHLERPLEIN 3, AMSTERDAM, P7, 1082 MS · 31 20 462 6644

Reported Value
$402M
Q3 2024
Positions
82
Filings on Record
20
2019–present window
Filed
Nov 1, 2024
original filing

Summary

Privium Fund Management B.V. reported $402M in U.S.-listed holdings across 82 positions for Q3 2024.

Its largest position, TSLA, represents 14.0% of the portfolio.

Compared with Q2 2024, the fund opened 12 new positions and exited 59.

Portfolio Metrics

Turnover
+17.7%
vs prior filed quarter
Top-10 Concentration
+65.7%
share of reported value
Largest Position
+14.0%
Tesla
New / Exited
12 / 59
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’21: $504MQ4 ’21Q1 ’22: $452MQ2 ’22: $302MQ3 ’22: $275MQ3 ’22Q4 ’22: $264MQ1 ’23: $298MQ2 ’23: $347MQ2 ’23Q3 ’23: $336MQ4 ’23: $359MQ1 ’24: $374MQ1 ’24Q2 ’24: $392MQ3 ’24: $402MQ4 ’24: $442MQ4 ’24Q1 ’25: $384MQ2 ’25: $464MQ3 ’25: $556MQ3 ’25Q4 ’25: $543MQ1 ’26: $480Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 73.2%Other: 19.6%ADR: 6.9%US DOMESTIC: 0.2%ETP: 0.1%
  • Common Stock · 73.2% · $294M
  • Other · 19.6% · $79M
  • ADR · 6.9% · $28M
  • US DOMESTIC · 0.2% · $720,000
  • ETP · 0.1% · $406,313

Quarter-over-Quarter Changes full breakdown →

vs Q2 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ASTSAST SPACEMOBILE INCNEW+821.3K821.3K+$21M$21M
OXYOCCIDENTAL PETE CORPNEW+81.2K81.2K+$4M$4M
TILEINTERFACE INCNEW+26.8K26.8K+$508,396$508,396
SPROTT FDS TRNEW+8.9K8.9K+$406,313$406,313
WAVE LIFE SCIENCES LTDNEW+48.8K48.8K+$400,439$400,439
ONTMONTROSE ENVIRONMENTAL GROUPNEW+13.3K13.3K+$350,448$350,448
NGVCNATURAL GROCERS BY VITAMIN CNEW+11.0K11.0K+$325,818$325,818
NTLAINTELLIA THERAPEUTICS INCNEW+12.3K12.3K+$252,765$252,765

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2024

50 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1TSLATESLA INChistory →COM14.03%$56M216.0K
2SPOTIFY TECHNOLOGY S ASHS13.67%$55M149.0K
3SHOPSHOPIFY INChistory →CL A8.23%$33M415.0K
4AMZNAMAZON COM INChistory →COM6.56%$26M141.0K
5ASTSAST SPACEMOBILE INChistory →COM CL A5.34%$21M821.3K
6SESEA LTDhistory →SPONSORD ADS4.93%$20M210.0K
7PLTRPALANTIR TECHNOLOGIES INChistory →CL A4.38%$18M475.0K
8RAREULTRAGENYX PHARMACEUTICAL INhistory →COM3.35%$13M242.5K
9SNOWSNOWFLAKE INChistory →CL A2.71%$11M95.0K
10PROQR THRAPEUTICS N VSHS EURO2.55%$10M5.63M
11ISIIONIS PHARMACEUTICALS INChistory →COM2.50%$10M250.7K
12NVDANVIDIA CORPORATIONhistory →COM2.20%$9M73.0K
13ITCIEURINTRA-CELLULAR THERAPIES INChistory →COM2.15%$9M118.0K
14DDOGDATADOG INChistory →CL A COM1.88%$8M66.0K
15AMDADVANCED MICRO DEVICES INChistory →COM1.80%$7M44.0K
16AXSMAXSOME THERAPEUTICS INChistory →COM1.79%$7M80.2K
17MRKMERCK & CO INChistory →COM1.70%$7M60.1K
18GOOGLALPHABET INChistory →CAP STK CL A1.65%$7M40.0K
19ARWRARROWHEAD PHARMACEUTICALS INhistory →COM1.61%$6M333.4K
20ROIVANT SCIENCES LTDSHS1.39%$6M484.5K
21RCKTROCKET PHARMACEUTICALS INChistory →COM1.35%$5M294.8K
22ZLABZAI LAB LTDhistory →ADR1.29%$5M215.6K
23CPNGCOUPANG INChistory →CL A1.24%$5M201.9K
24NETCLOUDFLARE INChistory →CL A COM1.21%$5M60.0K
25MSFTMICROSOFT CORPhistory →COM1.07%$4M10.0K
26OXYOCCIDENTAL PETE CORPhistory →COM1.04%$4M81.2K
27UNIQURE NVSHS0.91%$4M744.9K
28MRNAMODERNA INCCOM0.67%$3M40.5K
29ACADACADIA PHARMACEUTICALS INCCOM0.57%$2M148.4K
30ABEVAMBEV SASPONSORED ADR0.38%$2M622.3K
31CRISPR THERAPEUTICS AGNAMEN AKT0.35%$1M30.3K
32RNAGBPAVIDITY BIOSCIENCES INCCOM0.29%$1M25.6K
33KRYSKRYSTAL BIOTECH INCCOM0.29%$1M6.3K
34FDMT4D MOLECULAR THERAPEUTICS INCOM0.26%$1M98.5K
35ALXOALX ONCOLOGY HLDGS INCCOM0.23%$926,487509.1K
36MEIRAGTX HLDGS PLCCOM0.22%$892,213214.0K
37TRVCCITIGROUP INCCOM NEW0.20%$801,53012.8K
38FNVFRANCO NEV CORPCOM0.19%$753,0796.1K
39BEYOND MEAT INCNOTE 3/10.18%$720,0004.50M
40AUTLAUTOLUS THERAPEUTICS PLCSPON ADS0.17%$673,870185.6K
41PFEPFIZER INCCOM0.16%$636,04422.0K
42NOVNOV INCCOM0.15%$605,66237.9K
43AIGAMERICAN INTL GROUP INCCOM NEW0.15%$587,5988.0K
44BTUPEABODY ENERGY CORPCOM0.14%$561,05621.1K
45PAASPAN AMERN SILVER CORPCOM0.14%$552,72126.5K
46AZEKAZEK CO INCCL A0.13%$540,54011.6K
47DYNDYNE THERAPEUTICS INCCOM0.13%$539,37515.0K
48SEA1EURSEABRIDGE GOLD INCCOM0.13%$538,74132.1K
49RXRXRECURSION PHARMACEUTICALS INCL A0.13%$514,02078.0K
50TILEINTERFACE INCCOM0.13%$508,39626.8K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$480M60May 5, 202613F-HRchanges · EDGAR ↗
Q4 2025$543M57Feb 3, 202613F-HRchanges · EDGAR ↗
Q3 2025$556M59Nov 4, 202513F-HRchanges · EDGAR ↗
Q2 2025$464M55Jul 30, 202513F-HRchanges · EDGAR ↗
Q1 2025$384M56May 9, 202513F-HRchanges · EDGAR ↗
Q4 2024$442M64Feb 11, 202513F-HRchanges · EDGAR ↗
Q3 2024$402M82Nov 1, 202413F-HRchanges · EDGAR ↗
Q2 2024$392M129Aug 1, 202413F-HRchanges · EDGAR ↗
Q1 2024$374M117Apr 30, 202413F-HRchanges · EDGAR ↗
Q4 2023$359M114Feb 26, 2024RESTATEMENTchanges · EDGAR ↗
Q3 2023$336M115Nov 6, 202313F-HRchanges · EDGAR ↗
Q2 2023$347M124Jul 26, 2023RESTATEMENTchanges · EDGAR ↗
Q1 2023$298M126May 3, 202313F-HRchanges · EDGAR ↗
Q4 2022$264M150Feb 3, 202313F-HRchanges · EDGAR ↗
Q3 2022$275M226Nov 3, 202213F-HRchanges · EDGAR ↗
Q2 2022$302M252Jul 28, 202213F-HRchanges · EDGAR ↗
Q1 2022$452M279May 10, 202213F-HRchanges · EDGAR ↗
Q4 2021$504M253Feb 9, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.